News

GLP-1 receptor agonist use linked to lower mortality in seniors with cancer, T2D

For older patients with cancer and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is ...
HealthDay on MSN5d

GLP-1 Receptor Agonists May Improve Outcomes in Idiopathic Intracranial Hypertension

For patients with idiopathic intracranial hypertension, GLP-1 RA treatment is linked to improved clinical outcomes compared with conventional therapies.

Brain peptide ODN reduces hunger and boosts glucose regulation in rat study

University of Pennsylvania and Syracuse University scientists have discovered that a hindbrain-derived peptide, octadecaneuropeptide (ODN), can suppress appetite and improve glucose regulation without ...